146 related articles for article (PubMed ID: 38565691)
1. Effects of palliative intrathecal analgesia on patients with refractory cancer bone pain.
Haraga I; Kosugi T; Sadashima E; Yumiba T; Kubo M; Ishikawa-Konishi A; Akiyoshi K
J Anesth; 2024 Jun; 38(3):405-411. PubMed ID: 38565691
[TBL] [Abstract][Full Text] [Related]
2. Spinal analgesia for severe cancer pain: A retrospective analysis of 60 patients.
Kiehelä L; Hamunen K; Heiskanen T
Scand J Pain; 2017 Jul; 16():140-145. PubMed ID: 28850391
[TBL] [Abstract][Full Text] [Related]
3. A successful palliative care intervention for cancer pain refractory to intrathecal analgesia.
Reddy A; Hui D; Bruera E
J Pain Symptom Manage; 2012 Jul; 44(1):124-30. PubMed ID: 22652136
[TBL] [Abstract][Full Text] [Related]
4. 'Was it worth it?' Intrathecal analgesia for cancer pain: A qualitative study exploring the views of family carers.
Patel N; Huddart M; Makins H; Mitchell T; Gibbins JL; Graterol J; Stevens D; Perkins P
Palliat Med; 2018 Jan; 32(1):287-293. PubMed ID: 28832240
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Intrathecal Analgesia With a Wireless Analgesia Pump System in the Home Care of Patients With Advanced Cancer.
Liu HJ; Li WY; Chen HF; Cheng ZQ; Jin Y
Am J Hosp Palliat Care; 2017 Mar; 34(2):148-153. PubMed ID: 26537661
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal infusions for intractable cancer pain: a qualitative study of the impact on a case series of patients and caregivers.
Hawley P; Beddard-Huber E; Grose C; McDonald W; Lobb D; Malysh L
Pain Res Manag; 2009; 14(5):371-9. PubMed ID: 19862372
[TBL] [Abstract][Full Text] [Related]
7. Movement-evoked breakthrough cancer pain despite intrathecal analgesia: a prospective series.
Bäckryd E; Larsson B
Acta Anaesthesiol Scand; 2011 Oct; 55(9):1139-46. PubMed ID: 22092213
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal Analgesia via a Percutaneous Port With Patient-Controlled Intrathecal Analgesia for the Management of Movement-Evoked Breakthrough Cancer Pain of Refractory Lower Extremity Cancer Pain: A Retrospective Review.
Zhou L; Guo Z
Pain Physician; 2023 Jul; 26(4):375-382. PubMed ID: 37535777
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal catheter-syringe adaptor for short-term intrathecal analgesia with an externalized pump: a case report.
Wilkes D; Cook M; Solanki D
Pain Physician; 2010; 13(2):151-6. PubMed ID: 20309381
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of intrathecal drug delivery system for intractable pain in advanced malignancies: A prospective cohort study.
Zheng S; He L; Yang X; Li X; Yang Z
Medicine (Baltimore); 2017 Mar; 96(11):e6354. PubMed ID: 28296770
[TBL] [Abstract][Full Text] [Related]
11. Continuous intrathecal meperidine for severe refractory cancer pain: a case report.
Souter KJ; Davies JM; Loeser JD; Fitzgibbon DR
Clin J Pain; 2005; 21(2):193-6. PubMed ID: 15722815
[TBL] [Abstract][Full Text] [Related]
12. Palliative care with cervical intrathecal infusion and external pump for a late-stage cancer patient with refractory pain: A case report.
Ju Y; Tian D; Tan Y; Fu Z
Medicine (Baltimore); 2018 Jan; 97(4):e9714. PubMed ID: 29369202
[TBL] [Abstract][Full Text] [Related]
13. Effect of intrathecal dexmedetomidine on spinal morphine analgesia in patients with refractory cancer pain.
Liu HJ; Gao XZ; Liu XM; Xia M; Li WY; Jin Y
J Palliat Med; 2014 Jul; 17(7):837-40. PubMed ID: 24702571
[TBL] [Abstract][Full Text] [Related]
14. Successful Control of Pain from Malignant Psoas Syndrome by Spinal Opioid with Local Anesthetic Agents.
Yamaguchi T; Katayama K; Matsumoto M; Sato Y; Nakayama N; Hisahara K
Pain Pract; 2018 Jun; 18(5):641-646. PubMed ID: 28940900
[TBL] [Abstract][Full Text] [Related]
15. Daily subcutaneous parecoxib injection for cancer pain: an open label pilot study.
Kenner DJ; Bhagat S; Fullerton SL
J Palliat Med; 2015 Apr; 18(4):366-72. PubMed ID: 25695199
[TBL] [Abstract][Full Text] [Related]
16. Epidural and intrathecal analgesia is effective in treating refractory cancer pain.
Burton AW; Rajagopal A; Shah HN; Mendoza T; Cleeland C; Hassenbusch SJ; Arens JF
Pain Med; 2004 Sep; 5(3):239-47. PubMed ID: 15367301
[TBL] [Abstract][Full Text] [Related]
17. Evolving spinal analgesia practice in palliative care.
Baker L; Lee M; Regnard C; Crack L; Callin S;
Palliat Med; 2004 Sep; 18(6):507-15. PubMed ID: 15453621
[TBL] [Abstract][Full Text] [Related]
18. Opioid Rotation to Methadone for Refractory Cancer Pain: A Case Series.
Khoo SY; Aziz FA; Nambbiar P
J Pain Palliat Care Pharmacother; 2019; 33(3-4):125-130. PubMed ID: 31638444
[TBL] [Abstract][Full Text] [Related]
19. Case study report of two palliative care patients receiving intracerebroventricular (ICV) analgesia.
Vojkovic SJ; Kristjanson LJ
J Palliat Care; 2003; 19(4):280-3. PubMed ID: 14959600
[No Abstract] [Full Text] [Related]
20. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
